The Ensign Group (NASDAQ:ENSG) Stock Rating Raised to Buy at Wall Street Zen

Key Points

• Wall Street Zen upgraded The Ensign Group from “hold” to “buy,” while the broader analyst consensus remains “Moderate Buy” with an average price target of $216.25.
• Ensign exceeded quarterly earnings expectations, reporting $1.92 in EPS versus the $1.80 consensus, while revenue rose 16.7% year over year to $1.44 billion.
• Legal uncertainty remains a risk: a pending securities class action alleges patient-care, staffing, billing and licensing issues, though the claims have not been proven. Institutional investors own approximately 96.12% of the stock.

The Ensign Group (NASDAQ:ENSG - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a report released on Sunday, Wall Street Zen reports.

ENSG has been the topic of several other reports. Royal Bank Of Canada reissued an "outperform" rating and set a $228.00 price target on shares of The Ensign Group in a research report on Tuesday, July 28th. Truist Financial increased their price objective on shares of The Ensign Group from $202.00 to $207.00 and gave the company a "hold" rating in a research report on Thursday, July 30th. Finally, Weiss Ratings upgraded shares of The Ensign Group from a "buy (b-)" rating to a "buy (b)" rating in a research note on Thursday, October 8th. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, The Ensign Group has an average rating of "Moderate Buy" and an average target price of $216.25.

The Ensign Group Stock Down 1.5%

Shares of NASDAQ ENSG opened at $175.59 on Friday. The Ensign Group has a 12-month low of $141.58 and a 12-month high of $218.00. The company has a market cap of $10.23 billion, a P/E ratio of 27.52, a P/E/G ratio of 1.66 and a beta of 0.66. The company has a current ratio of 1.21, a quick ratio of 1.21 and a debt-to-equity ratio of 0.06. The stock has a fifty day moving average price of $174.77 and a 200 day moving average price of $174.76.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last issued its quarterly earnings data on Monday, July 27th. The company reported $1.92 EPS for the quarter, topping analysts' consensus estimates of $1.80 by $0.12. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%. The company had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.44 billion. During the same quarter in the previous year, the firm posted $1.59 earnings per share. The firm's quarterly revenue was up 16.7% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Research analysts anticipate that The Ensign Group will post 7.04 EPS for the current fiscal year.

Institutional Trading of The Ensign Group

Large investors have recently modified their holdings of the business. Apollon Wealth Management LLC grew its position in shares of The Ensign Group by 22.9% in the 3rd quarter. Apollon Wealth Management LLC now owns 6,986 shares of the company's stock worth $1,202,000 after acquiring an additional 1,300 shares in the last quarter. Citizens Financial Group Inc. RI bought a new stake in shares of The Ensign Group in the 3rd quarter valued at approximately $254,000. Evergreen Capital Management LLC increased its holdings in shares of The Ensign Group by 13.3% in the 3rd quarter. Evergreen Capital Management LLC now owns 3,735 shares of the company's stock valued at $643,000 after acquiring an additional 437 shares during the last quarter. Wedbush Securities Inc. bought a new stake in shares of The Ensign Group in the 3rd quarter valued at approximately $207,000. Finally, Fifth Third Wealth Advisors LLC increased its holdings in shares of The Ensign Group by 12.6% in the 3rd quarter. Fifth Third Wealth Advisors LLC now owns 2,864 shares of the company's stock valued at $493,000 after acquiring an additional 320 shares during the last quarter. 96.12% of the stock is currently owned by institutional investors and hedge funds.

More The Ensign Group News

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Analyst commentary from Zacks continues to characterize Ensign as a potentially attractive long-term growth stock, supporting the company’s broader investment case. Why Ensign Group is a Top Growth Stock for the Long-Term
• Neutral Sentiment: The Ensign Group expects to release third-quarter 2026 financial results on October 27 and hold an earnings call on October 28. Investors will be watching operating performance, skilled-nursing demand, reimbursement trends and updated guidance for new catalysts or additional risk. Ensign Schedules Third Quarter 2026 Earnings Call
• Negative Sentiment: Several law firms publicized a pending securities class action against Ensign and certain executives. The case covers investors who purchased securities from February 10, 2022, through June 18, 2026, with a December 7, 2026 lead-plaintiff deadline. The complaints allege that the company concealed patient neglect, understaffing, manipulated quality and staffing data, improper billing and an administrator-license rental scheme. These allegations have not been proven, but the litigation creates potential legal costs, reputational damage and uncertainty around future operating results. Ensign Securities Notice and Class Action Allegations

About The Ensign Group

The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.

Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.

Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.